683 Capital Management, LLC
Position in PRAX — Praxis Precision Medicines, Inc.
CIK 1404574
NEW YORK, NY
Position in PRAX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
6 quarters on record
Derivatives in PRAX
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$36,960,816
PutShares
110,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026683 Capital Management, LLC holds $349,034,024 across 34 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANAB |
Anaptysbio, Inc
|
660,000 | $44,550,000 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
290,000 | $35,548,200 | |
| 3 | MGTX |
MeiraGTx Holdings plc
|
2,300,000 | $31,073,000 | |
| 4 | WVE |
Wave Life Sciences, Inc.
|
4,950,000 | $28,759,500 | |
| 5 | QURE |
uniQure N.V.
|
575,000 | $26,484,500 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
389,081 | $21,376,110 | |
| 7 | PHAT |
Phathom Pharmaceuticals, Inc.
|
1,850,000 | $20,072,500 | |
| 8 | TRAX |
First Tracks Biotherapeutics, Inc.
|
750,000 | $15,090,000 |
All Filings in PRAX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,960,816 | 110,400 | Put | Defined | 2026-08-14 | |
| 2026-03-31 | $36,310,813 | 112,700 | Put | Defined | 2026-05-15 | |
| 2025-12-31 | $50,046,852 | 169,800 | Put | Defined | 2026-02-17 | |
| 2025-06-30 | $3,124,315 | 74,300 | Put | Defined | 2025-08-14 | |
| 2025-03-31 | $3,571,141 | 94,300 | Put | Defined | 2025-05-15 | |
| 2023-12-31 | $255,796 | 11,481 | Shares | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||